{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:11:17Z","timestamp":1791090677722,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rheumatoid arthritis (RA) is an autoimmune synovitis characterized by the formation of pannus and the destruction of cartilage and bone in the synovial joints. Although immune cells, which infiltrate the pannus and promote inflammation, play a prominent role in the pathogenesis of RA, other cell types also contribute. Proliferation of synovial fibroblasts, for example, underlies the formation of the pannus, while proliferation of endothelial cells results in neovascularization, which supports the growth of the pannus by supplying it with nutrients and oxygen. The synovial fibroblasts also promote inflammation in the synovium by producing cytokines and chemokines. Finally, osteoclasts cause the destruction of bone. In this study, we show that erlotinib, an inhibitor of the tyrosine kinase epidermal growth factor receptor (EGFR), reduces the severity of established collagen-induced arthritis, a mouse model of RA, and that it does so by targeting synovial fibroblasts, endothelial cells, and osteoclasts. Erlotinib-induced attenuation of autoimmune arthritis was associated with a reduction in number of osteoclasts and blood vessels, and erlotinib inhibited the formation of murine osteoclasts and the proliferation of human endothelial cells in vitro. Erlotinib also inhibited the proliferation and cytokine production of human synovial fibroblasts in vitro. Moreover, EGFR was highly expressed and activated in the synovium of mice with collagen-induced arthritis and patients with RA. Taken together, these findings suggest that EGFR plays a central role in the pathogenesis of RA and that EGFR inhibition may provide benefits in the treatment of RA.<\/jats:p>","DOI":"10.4049\/jimmunol.1102693","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T05:07:52Z","timestamp":1331010472000},"page":"3513-3521","source":"Crossref","is-referenced-by-count":66,"title":["Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase Ameliorates Collagen-Induced Arthritis"],"prefix":"10.1093","volume":"188","author":[{"given":"Christina D","family":"Swanson","sequence":"first","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"},{"name":"Veterans Affairs Palo Alto Health Care System , Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot H","family":"Akama-Garren","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A","family":"Stein","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"},{"name":"Veterans Affairs Palo Alto Health Care System , Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D","family":"Petralia","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolhossein","family":"Edalati","sequence":"additional","affiliation":[{"name":"Veterans Affairs Palo Alto Health Care System , Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin M","family":"Lindstrom","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"},{"name":"Veterans Affairs Palo Alto Health Care System , Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H","family":"Robinson","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA 94305"},{"name":"Veterans Affairs Palo Alto Health Care System , Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,4,1]]},"reference":[{"key":"2025032409593323000_r1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2412","article-title":"T cells in rheumatoid arthritis","volume":"10","author":"Cope","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"2025032409593323000_r2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"2025032409593323000_r3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI5929","article-title":"Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis","volume":"103","author":"Firestein","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2025032409593323000_r4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2110","article-title":"Cells of the synovium in rheumatoid arthritis: osteoclasts","volume":"9","author":"Schett","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"2025032409593323000_r5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/RHU.0b013e3181c8e176","article-title":"Cetuximab in the treatment of rheumatoid arthritis","volume":"16","author":"Sullivan","year":"2010","journal-title":"J. Clin. Rheumatol."},{"key":"2025032409593323000_r6","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/art.23885","article-title":"Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen-induced arthritis","volume":"58","author":"Sumariwalla","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2025032409593323000_r7","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1186\/ar3480","article-title":"Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade","volume":"13","author":"Gompels","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"2025032409593323000_r8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"2025032409593323000_r9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-9255-5-5","article-title":"Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients","volume":"5","author":"Yamane","year":"2008","journal-title":"J. Inflamm. (Lond.)"},{"key":"2025032409593323000_r10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780270106","article-title":"Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis","volume":"27","author":"Young","year":"1984","journal-title":"Arthritis Rheum."},{"key":"2025032409593323000_r11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.52.12.870","article-title":"Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis","volume":"52","author":"Farahat","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"2025032409593323000_r12","first-page":"859","article-title":"Immuno-reactive human epidermal growth factor (h-EGF) in rheumatoid synovial fluids","volume":"67","author":"Kusada","year":"1993","journal-title":"Nippon Seikeigeka Gakkai Zasshi"},{"key":"2025032409593323000_r13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clpt.2006.04.007","article-title":"Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer","volume":"80","author":"Lu","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"2025032409593323000_r14","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1172\/JCI28546.","article-title":"Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis","volume":"116","author":"Paniagua","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2025032409593323000_r15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.cad.0000127664.66472.60","article-title":"Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models","volume":"15","author":"Higgins","year":"2004","journal-title":"Anticancer Drugs"},{"issue":"3","key":"2025032409593323000_r16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0093-7754(03)70012-8","article-title":"Pharmacokinetics and pharmacodynamics: maximizing the clinical potential of Erlotinib (Tarceva)","volume":"30","author":"Hidalgo","year":"2003","journal-title":"Semin. Oncol."},{"key":"2025032409593323000_r17","first-page":"20","article-title":"The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases","volume":"64","author":"Abeles","year":"2006","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"2025032409593323000_r18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/1043-4666(90)90009-I","article-title":"Autocrine regulation of rheumatoid arthritis synovial cell growth in vitro","volume":"2","author":"Goddard","year":"1990","journal-title":"Cytokine"},{"key":"2025032409593323000_r19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/ard.2007.072330","article-title":"Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts","volume":"67","author":"Huber","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"2025032409593323000_r20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00270247","article-title":"Comparative and combined effects of transforming growth factors \u03b1 and \u03b1, interleukin-1 and interferon-gamma on rheumatoid synovial cell proliferation, glycolysis and prostaglandin E production","volume":"9","author":"Taylor","year":"1989","journal-title":"Rheumatol. Int."},{"key":"2025032409593323000_r21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00296-009-0976-6","article-title":"Epidermal growth factor increases prostaglandin E2 production via ERK1\/2 MAPK and NF-\u03baB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis","volume":"30","author":"Nah","year":"2010","journal-title":"Rheumatol. Int."},{"key":"2025032409593323000_r22","first-page":"557","article-title":"Angiogenesis in rheumatoid arthritis","volume":"21","author":"Maruotti","year":"2006","journal-title":"Histol. Histopathol."},{"key":"2025032409593323000_r23","first-page":"245","article-title":"Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints","volume":"10","author":"Endo","year":"1991","journal-title":"Lymphokine Cytokine Res."},{"key":"2025032409593323000_r24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1096-9896(199705)182:1<106::AID-PATH816>3.0.CO;2-A","article-title":"The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats","volume":"182","author":"Ogata","year":"1997","journal-title":"J. Pathol."},{"key":"2025032409593323000_r25","first-page":"644","article-title":"Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1\u03b2","volume":"23","author":"Ainola","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"2025032409593323000_r26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/ard.50.11.792","article-title":"Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis","volume":"50","author":"FitzGerald","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"2025032409593323000_r27","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1074\/jbc.275.7.5096","article-title":"Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation","volume":"275","author":"Wu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2025032409593323000_r28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08977190701773070","article-title":"HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways","volume":"25","author":"Mehta","year":"2007","journal-title":"Growth Factors"},{"key":"2025032409593323000_r29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/08977190802393596","article-title":"HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis","volume":"26","author":"Mehta","year":"2008","journal-title":"Growth Factors"},{"key":"2025032409593323000_r30","first-page":"289","article-title":"Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow","volume":"312","author":"Semino","year":"2006","journal-title":"Exp. Cell Res."},{"key":"2025032409593323000_r31","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.2174\/138161207781368819","article-title":"Efficacy of the newest COX-2 selective inhibitors in rheumatic disease","volume":"13","author":"Baraf","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"2025032409593323000_r32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8","article-title":"Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases","volume":"41","author":"Siegle","year":"1998","journal-title":"Arthritis Rheum."},{"key":"2025032409593323000_r33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0014-4800(03)00019-4","article-title":"The role of COX-2 in angiogenesis and rheumatoid arthritis","volume":"74","author":"Woods","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"2025032409593323000_r34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2009.175","article-title":"Promising bone-related therapeutic targets for rheumatoid arthritis","volume":"5","author":"Choi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"2025032409593323000_r35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00296-009-1333-5","article-title":"Evaluation of inflammatory change and bone erosion using a murine type II collagen-induced arthritis model","volume":"31","author":"Choi","year":"2011","journal-title":"Rheumatol. Int."},{"key":"2025032409593323000_r36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/104454902320308915","article-title":"Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis","volume":"21","author":"Rho","year":"2002","journal-title":"DNA Cell Biol."},{"key":"2025032409593323000_r37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03026317","article-title":"Roles for NF-\u03baB and c-Fos in osteoclasts","volume":"23","author":"Boyce","year":"2005","journal-title":"J. Bone Miner. Metab."},{"key":"2025032409593323000_r38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jcp.21511","article-title":"Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling","volume":"217","author":"Yi","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"2025032409593323000_r39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/MCB.16.1.369","article-title":"Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor","volume":"16","author":"Leaman","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"2025032409593323000_r40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/dnares\/dsl006","article-title":"Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients","volume":"13","author":"Nakamura","year":"2006","journal-title":"DNA Res."},{"key":"2025032409593323000_r41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/03009740510017715","article-title":"TGF-\u03b1 and ErbB2 production in synovial joint tissue: increased expression in arthritic joints","volume":"34","author":"Hallbeck","year":"2005","journal-title":"Scand. J. Rheumatol."},{"key":"2025032409593323000_r42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1096\/fj.02-1209fje","article-title":"Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3\u2032-kinase in endothelial cell","volume":"17","author":"Kim","year":"2003","journal-title":"FASEB J."},{"key":"2025032409593323000_r43","doi-asserted-by":"crossref","first-page":"53848","DOI":"10.1074\/jbc.M403114200","article-title":"Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2025032409593323000_r44","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"2025032409593323000_r45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2249.2008.03691.x","article-title":"Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis","volume":"153","author":"Fabre","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"2025032409593323000_r46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10555-010-9201-z","article-title":"Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy","volume":"29","author":"Gazdar","year":"2010","journal-title":"Cancer Metastasis Rev."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/188\/7\/3513\/62484151\/1102693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/188\/7\/3513\/62484151\/1102693.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:58:15Z","timestamp":1743101895000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/188\/7\/3513\/7981288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,1]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,4,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1102693","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,4]]},"published":{"date-parts":[[2012,4,1]]}}}